Table: begin end state 1 19 cytoplasmic 20 41 transmembrane 42 46 non-cytoplasmic 47 71 transmembrane 72 82 cytoplasmic 83 103 transmembrane 104 108 non-cytoplasmic 109 135 transmembrane 136 147 cytoplasmic 148 170 transmembrane 171 181 non-cytoplasmic 182 202 transmembrane 203 235 cytoplasmic 236 259 transmembrane 260 270 non-cytoplasmic 271 293 transmembrane 294 301 cytoplasmic 302 321 transmembrane 322 326 non-cytoplasmic 327 350 transmembrane 351 363 cytoplasmic 364 387 transmembrane 388 393 non-cytoplasmic 394 416 transmembrane 417 433 cytoplasmic
Input: >Pf1N1B4_183 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_183 MHTTPQPRRAAAAAFIGTTIEFYDFYIYATAAALVLGQVFFPSHDPVMSTLAAFGSFAVG FIARPMAGMVFGHLGDRLGRKKMLLVTMALMGLATTGIGMLPSYASAGIWAPIGLIVLRL IQGISVGGEWGGAVLMASEHAPAKRKTFYASFAQLGSPAGLLLALIAFRLVTSLEPEDFL AWGWRLPFLASGVLMMVGLMIRSGVHESPEFAKAKDNNETAKYPVKDVIRTCWRQILFAA AAVTIGSAGFFFTNTFMITYVTQYQGIPRSTILDCLFLVTVIQLLSQPLSALLAERIGEG RFLKLVALLCMVTPYPMFLLVGTQNIVLMTVGIALAVVILSALYAVIAGYMTQAFPVHLR YSGISIAYQLSCALAGGTTPLIGTLLASKFSGQWLPLAVFFTLLSALSLIGVCGLARLRA NPVATHAAKEVYS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server